drugset
drugset / Trial / NCT05319834

Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth

NCT05319834 ↗

Phase 4 Completed 256 enrolled Menoufia University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a double blinded randomized placebo controlled clinical trial to detect the efficacy and safety of vaginal progesterone alone or combined with aspirin in prevention of recurrent PTB.

Timeline

Start
2022-04-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg Oral

Indications

No indication recorded.